Risk of Price Fluctuations in Securities Held
First written in FY2016. 9 of 15 entries say "Mitigated", first in FY2018. Latest entry: FY2026.
The whole theme swung hardest in 2019: 17 of 49 companies on the "Worse" side.
23 other companies' latest entry also says "Mitigated".
- FY2026MitigatedAnnual report
「12 unlisted shares: ¥75 million; 11 shares other than unlisted shares: ¥2,137 million」
Strategically held shares comprised 23 securities with a total carrying amount of ¥2,212 million, and 2 listed shares were sold during the fiscal year. The policy of reducing the number and balance of holdings remains in place. - FY2023MitigatedAnnual report
「The holdings comprised 13 unlisted shares and 16 shares other than unlisted shares, for a total balance-sheet carrying amount of ¥1,130 million.」
The carrying amount of strategically held shares decreased from ¥6,634 million in the previous fiscal year to ¥1,130 million, reducing exposure to price volatility. - FY2023-Q3MitigatedAnnual report
「This was attributable to a decrease in investment securities following a reduction in accounts receivable and the sale of strategically held shares, while inventories increased as a result of higher production.」
Investment securities decreased following the sale of strategically held shares, and the reduction in exposure to price volatility risk continues. - FY2022-Q3MitigatedAnnual report
「Gain on sale of investment securities: ¥3,249 million」
The company recorded a gain on the sale of investment securities of ¥3,249 million through the sale of strategically held shares and other securities, while the balance of investment securities decreased from ¥10,828 million at the end of the previous consolidated fiscal year to ¥6,248 million. Exposure to price volatility is being reduced. - FY2022-Q1MitigatedAnnual report
「This was attributable to increases in receivables resulting from higher sales and in inventories resulting from increased production, while investment securities decreased following the sale of strategically held shares.」
The balance of investment securities decreased following the sale of strategically held shares, and the reduction in exposure to price volatility continues. - FY2021MitigatedAnnual report
「Number of securities: 14 31; total balance-sheet carrying amount (¥ million): 78 6,634」
Strategically held shares comprised 14 unlisted and 31 listed securities, and 4 listed shares were sold during the fiscal year. The reduction in the number and carrying amount of holdings remains ongoing. - FY2021-Q3MitigatedAnnual report
「This resulted from the sale of 1 domestically listed stock among the investment securities held by the Company.」
The company sold 1 listed domestic share and recorded a gain on the sale of investment securities of ¥152 million. Measures to reduce exposure to price volatility in held securities remain ongoing. - FY2020MitigatedAnnual report
「Each year, the company’s Board of Directors specifically verifies whether the purpose of holding each strategically held share is appropriate and whether the benefits and risks associated with holding it are commensurate with the cost of capital, among other matters, and determines whether reducing the holdings is appropriate.」
The company explicitly stated that it conducts an annual review, including comparison with the cost of capital, and decides whether to reduce its strategically held shares. The holdings comprised 14 unlisted and 33 listed securities, for a total carrying amount of ¥5,293 million. - FY2020-Q2WorsenedAnnual report
「Impairment loss on investment securities: ¥136 million」
An impairment loss on investment securities of ¥136 million was recorded, and the realized loss attributable to price volatility risk in held securities increased. - FY2020-Q1WorsenedAnnual report
「Impairment loss on investment securities: ¥126 million」
An impairment loss on investment securities of ¥126 million was recorded in the first quarter, and the realized loss attributable to price volatility risk in held securities increased from the ¥37 million impairment loss recorded in the third quarter of the previous fiscal year. - FY2019-Q3MaterialisedAnnual report
「Impairment loss on investment securities: ¥37 million」
An impairment loss on investment securities of ¥37 million was recorded, and the price volatility risk of held securities was reflected in results. Meanwhile, the balance of investment securities decreased from ¥15,207 million at the end of the previous fiscal year to ¥13,630 million. - FY2018MitigatedAnnual report
「51 securities; total balance-sheet carrying amount: ¥11,058 million」
The number of strategically held securities and their balance-sheet carrying amount were disclosed, while exposure to price volatility in held securities decreased from the previous fiscal year. - FY2017RestatedAnnual report
「For investment securities, the company regularly monitors fair value, the financial condition of issuers, including business partners, and other factors, and continually reviews its holdings in light of its relationships with business partners.」
As price volatility risk for shares of business partners continues, the company is reaffirming its controls for monitoring market values and issuers’ financial conditions and reviewing its holdings. - FY2017-Q1MaterialisedAnnual report
「Although net assets increased due to an increase in retained earnings, they decreased by ¥867 million from the end of the previous consolidated fiscal year to ¥63,529 million, due to a decline in the market value of held shares and a decrease in the foreign currency translation adjustment resulting from currency movements.」
The decline in the market value of held shares was reflected in the decrease in net assets, and an investment securities valuation loss of ¥169 million was also recognised, indicating that the price fluctuation risk of held securities had materialised. - FY2016First statedAnnual report
「The Company holds shares in business partners and other companies involved in sales and procurement, and its business performance may be affected by fluctuations in the performance of its investees and securities markets.」
The Company holds shares in business partners and other companies and is exposed to fluctuations in investee performance and securities markets. The number of holdings is 56, and their amount recognised on the balance sheet is ¥12,056 million.